LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2025

Core Viewpoint - LifeVantage Corporation reported outstanding financial results for the second fiscal quarter of 2025, with a record revenue growth of over 31% year-over-year, driven by strong demand for its new MindBody GLP-1 System™ [4][5]. Financial Performance - Revenue for the second quarter ended December 31, 2024, was $67.8 million, representing a 31.3% increase compared to the same period in fiscal 2024. Excluding foreign currency impacts, revenue growth was approximately 31.9% [5][9]. - Revenue in the Americas increased by 46.3%, with the United States alone seeing a 48.8% increase. Conversely, revenue in the Asia/Pacific & Europe region decreased by 15.5%, with a constant currency decrease of approximately 13.7% [5][9]. - Gross profit for the quarter was $54.6 million, or 80.5% of revenue, up from 78.6% in the same period last year, attributed to a favorable product sales mix and reduced inventory costs [6]. - Net income for the quarter was $2.6 million, or $0.19 per diluted share, compared to a net loss of $0.7 million, or $0.05 per diluted share, in the prior year [11][12]. Operational Metrics - Active Accounts increased by 11.5% year-over-year, reaching a total of 146,000, with a notable 21.1% increase in the Americas [34]. - Active Independent Consultants in the Americas rose to 35,000, a 9.4% increase from the previous year, while Active Customers increased by 27% to 80,000 [34]. Expense Management - Commissions and incentives expense for the quarter was $32.5 million, or 48.0% of revenue, up from 42.1% in the prior year, reflecting higher qualifications in promotional programs [7]. - Selling, general and administrative (SG&A) expenses decreased to $18.6 million, or 27.5% of revenue, down from 38.9% in the same period last year [8]. Guidance and Future Outlook - The company raised its fiscal year 2025 revenue guidance to a range of $235 million to $245 million, up from the previous estimate of $200 million to $210 million. Adjusted EBITDA guidance was also increased to $21 million to $24 million [16].